MoneyWorks4Me

Glenmark Pharmaceuticals submits media release

17 Sep 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of media release titled ‘Glenmark Receives Orphan Drug Designation for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma’, which is self explanatory.  

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..